Literature DB >> 30567242

Metastatic lung adenocarcinoma- associated thrombotic microangiopathy in a renal transplant recipient.

Eswari Vilayur1,2, Jillian de Malmanche3, Paul Trevillian1,2, David Ferreira4,5.   

Abstract

Thrombotic microangiopathy (TMA) after renal transplantation can be a diagnostic challenge. TMA can occur with calcineurin inhibitors, allograft rejection, infection, mutations in complement regulatory proteins and autoimmunity. A 52-year-old male renal transplant recipient presented with extensive deep vein thrombosis. He developed transfusion-dependent microangiopathic haemolytic anaemia with thrombocytopenia. He did not respond calcineurin inhibitor cessation, eculizumab or plasma exchange. ADAMTS13 and complement levels were normal. Infection and autoimmune screens were negative. A diagnosis of metastatic adenocarcinoma was made on bone marrow biopsy. This represents a rare case of malignancy-associated TMA in a renal transplant recipient. Early diagnosis can facilitate the prompt initiation of chemotherapy which is the only treatment option. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute renal failure; haematology (incl blood transfusion); renal transplantation; respiratory cancer

Mesh:

Year:  2018        PMID: 30567242      PMCID: PMC6301462          DOI: 10.1136/bcr-2018-226707

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Thrombotic microangiopathy after kidney transplantation.

Authors:  M Noris; G Remuzzi
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

3.  Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.

Authors:  K Kojouri; S K Vesely; J N George
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

Review 4.  Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Authors:  Adam Cuker; Phyllis A Gimotty; Mark A Crowther; Theodore E Warkentin
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

Review 5.  Thrombotic microangiopathy after kidney transplantation.

Authors:  Claudio Ponticelli; Giovanni Banfi
Journal:  Transpl Int       Date:  2006-10       Impact factor: 3.782

6.  De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection.

Authors:  A A Satoskar; R Pelletier; P Adams; G M Nadasdy; S Brodsky; T Pesavento; M Henry; T Nadasdy
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

Review 7.  Thrombotic microangiopathy in renal allografts: the diagnostic challenge.

Authors:  Tibor Nadasdy
Journal:  Curr Opin Organ Transplant       Date:  2014-06       Impact factor: 2.640

Review 8.  Renal vascular and thrombotic effects of cyclosporine.

Authors:  G Remuzzi; T Bertani
Journal:  Am J Kidney Dis       Date:  1989-04       Impact factor: 8.860

9.  Histopathology and outcome of acute humoral rejection in renal allografts.

Authors:  Anjali A Satoskar; Ronald Pelletier; Gyongyi M Nadasdy; Mitchell Henry; Ronald Ferguson; Tibor Nadasdy
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

Review 10.  Cancer-associated thrombotic microangiopathy.

Authors:  K Govind Babu; Gita R Bhat
Journal:  Ecancermedicalscience       Date:  2016-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.